logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yoshiaki Nakamura

National Cancer Center Hospital East
H指数:40
被引数:9,288

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case Report: Discordance between RNA-identified ETV6::RET and clinically reportable DNA profiling in salivary gland secretory carcinoma

病例报告：涎腺分泌性癌中RNA鉴定ETV6::RET与临床可报告的DNA分型之间的不一致

Frontiers in Oncology
IF3.3
2026-09-280
OA
SB Shogen Boku; TF Takao Fujisawa; TS Tomofumi Sakagami; SK Shigenori Kadowaki; HS Hironaga Satake; HY Hisateru Yasui; KO Koushiro Ohtsubo; YS Yasushi Shimizu; TO Tomoyuki Otsuka; BK Bunya Kuze; RY Riu Yamashita; TS Taro Shibuki; YN Yoshiaki Nakamura; HB Hideaki Bando; TY Takayuki Yoshino; MR Milan Radovich; MY Masao Yagi; SO Susumu Okano
Longitudinal ctDNA profiling to guide anti-EGFR rechallenge in metastatic colorectal cancer: a prospective single-arm phase II trial

纵向ctDNA分析指导抗EGFR再挑战治疗在转移性结直肠癌中的应用：一项前瞻性单臂II期临床试验

Communications Medicine
IF6.3
2026-09-090
OAAI
Yoshinori Kagawa; Daisuke Kotani; Hiroya Taniguchi; Tadayoshi Hashimoto; Hideaki Bando; Naoki Takahashi; Tetsuya Hamaguchi; Akiyoshi Kanazawa; Takeshi Kato; Koji Ando; Hisateru Yasui; Eiji Shinozaki; Yu Sunakawa; Atsuo Takashima; Kentaro Yamazaki; Satoshi Yuki; Yoshiaki Nakamura; Masashi Wakabayashi; Hiromichi Nakajima; Takashi Ohta; Takayuki Yoshino
Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer

WES定义的ERBB2扩增在可切除结直肠癌中的临床意义

International Journal of Clinical Oncology
IF2.8
2026-08-200
OAAI
Kazuki Kishi; Atsushi Hamabe; Yusuke Suwa; Naoya Akazawa; Keiji Hirata; Masataka Ikeda; Mitsuru Yokota; Kentaro Kato; Masahito Kotaka; Yujiro Nishizawa; Hideaki Bando; Yoshiaki Nakamura; Saori Mishima; Tadayoshi Hashimoto; Arkarachai Fungtammasan; Charuta C. Palsuledesai; Robert W. Lentz; Daisuke Kotani; Hiroya Taniguchi; Jun Watanabe; Ichiro Takemasa; Takeshi Kato; Mamoru Uemura; Hidetoshi Eguchi; Yuichiro Doki; Eiji Oki; Takayuki Yoshino
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial

ctDNA阳性的结直肠癌患者术后辅助化疗: 一项随机3期试验

Nature Medicine
IF50
2026-06-080
OAAI
Hideaki Bando; Jun Watanabe; Yusuke Takahashi; Masahito Kotaka; Nobuhisa Matsuhashi; Eiji Oki; Yoshito Komatsu; Manabu Shiozawa; Keiji Hirata; Yuji Miyamoto; Masanobu Takahashi; Kentaro Yamazaki; Dai Manaka; Akiyoshi Kanazawa; Yi-Hsin Liang; Kun-Huei Yeh; Yuko Watsuji; Yuko Yamamoto; Makoto Fukui; Shruti Sharma; Vasily N. Aushev; Adham Jurdi; Matthew Rabinowitz; Minetta C. Liu; Alexey Aleshin; Ichiro Takemasa; Daisuke Kotani; Akihiro Sato; Toshihiro Misumi; Yoshiaki Nakamura; Qian Shi; Hiroya Taniguchi; Takayuki Yoshino; Takeshi Kato
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway

既往抗EGFR治疗和基线ctDNA分析对帕妥珠单抗联合曲妥珠单抗在HER2扩增转移性结直肠癌中的疗效影响：TRIUMPH/MyPathway整合分析

ESMO Open
IF8.3
2026-05-270
OAAI
Y. Matsubara; M. Wakabayashi; W. Okamoto; T. Kato; T. Esaki; K. Kato; Y. Komatsu; T. Masuishi; T. Nishina; H. Bando; T. Misumi; M. Fukui; S. Matsuda; Y. Ikeda; J. Malato; K. Schulze; R. Price; A. Sato; T. Yoshino; Y. Nakamura
Longitudinal remodeling of the tumor-immune microenvironment during regorafenib, nivolumab, and chemotherapy in advanced gastric cancer

在瑞戈菲尼、纳武利尤单抗和化疗过程中，晚期胃癌肿瘤-免疫微环境的纵向重塑

Science Translational Medicine
IF14.6
2026-01-010
PRE
Kota Itahashi; Akihito Kawazoe; Tadayoshi Hashimoto; Yue Yan; Takuma Irie; 小野宏美; Hitomi Tamura; Kyoko Hongo; Takashi Ikeno; Masashi Wakabayashi; Akihiro Sato; Yoshiaki Nakamura; Takao Fujisawa; Tomohiro Iwasawa; Tomoya Suzuki; Izuma Nakayama; Yasuhiro Kojima; Takayuki Yoshino; Hiroyoshi Nishikawa; Shohei Koyama; Kohei Shitara
Genomic alteration and clinical significance of circulating tumor DNA in patients with advanced urothelial cancer: SCRUM-Japan monstar screen project

基因组改变和循环肿瘤DNA在晚期尿路上皮癌患者中的临床意义：日本SCRUM-monstar筛查项目

npj Precision Oncology
IF8
2025-11-180
OAAI
Takahiro Osawa; Nobuaki Matsubara; Taigo Kato; Masaki Shiota; Koshiro Nishimoto; Takashige Abe; Nobuo Shinohara; Yota Yasumizu; Nobuyuki Tanaka; Mototsugu Oya; Hikaru Abutani; Takaaki Oda; Takao Fujisawa; Yoshiaki Nakamura; Smruthy Sivakumar; Masatoshi Eto; Takayuki Yoshino; Norio Nonomura
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701)

一项关于厄洛替尼用于BRAF V600E突变型转移性结直肠癌的多中心II期研究：BRAVERY研究（EPOC1701）

ESMO Open
IF8.3
2025-10-090
OAAI
T. Masuishi; H. Taniguchi; D. Kotani; H. Bando; Y. Komatsu; E. Shinozaki; Y. Sunakawa; T. Satoh; T. Nishina; T. Esaki; M. Wakabayashi; S. Nomura; K. Takahashi; H. Ono; N. Hirano; N. Fujishiro; N. Fuse; A. Sato; Y. Sakamoto; N. Kuramoto; I. Miki; H. Ichiki; Y. Nakamura; G. Sharma; S. Skrzypczak; E. Schultz; C. Kingsford; A. Ohtsu; T. Yoshino
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer

Claudin 18.2 表达对 HER2 阴性、 proficient MMR、PD-L1 CPS ⩾1 转移性胃/胃食管结合部癌患者一线免疫化疗治疗结局的影响

Therapeutic Advances in Medical Oncology
IF4.2
2025-09-200
OA
Fei Zhang; Izuma Nakayama; Naoya Sakamoto; Dai Okemoto; Amane Jubashi; Yuki Matsubara; Yu Miyashita; Seiya Sato; Shinpei Ushiyama; Akinori Kobayashi; Ukyo Okazaki; Kazumasa Yamamoto; Saori Mishima; Daisuke Kotani; Akihito Kawazoe; Tadayoshi Hashimoto; Yoshiaki Nakamura; Yasutoshi Kuboki; Hideaki Bando; Takashi Kojima; Takayuki Yoshino; Takeshi Kuwata; Kohei Shitara
HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancer

HIBRID：基于组织学的结直肠癌风险分层，结合深度学习和ctDNA

Nature Communications
IF15.7
2025-08-140
OAAI
Chiara M. L. Loeffler; Hideaki Bando; Srividhya Sainath; Hannah Sophie Muti; Xiaofeng Jiang; Marko van Treeck; Nic Gabriel Reitsam; Zunamys I. Carrero; Asier Rabasco Meneghetti; Tomomi Nishikawa; Toshihiro Misumi; Saori Mishima; Daisuke Kotani; Hiroya Taniguchi; Ichiro Takemasa; Takeshi Kato; Eiji Oki; Yuan Tanwei; Wankhede Durgesh; Sebastian Foersch; Hermann Brenner; Michael Hoffmeister; Yoshiaki Nakamura; Takayuki Yoshino; Jakob Nikolas Kather
A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901)

一项使用ASP-1929联合纳武利尤单抗治疗晚期胃癌的光免疫疗法Ib期研究（GE-PIT, EPOC1901）

GASTRIC CANCER
IF5.1
2025-05-150
PRE
Tomohiro Kadota; Rika Fujii; Shohei Koyama; Daisuke Kotani; Yusuke Yoda; Miki Fukutani; Mitsuko Suzuki; Masashi Wakabayashi; Takashi Ikeno; Hironori Sunakawa; Yoshiaki Nakamura; Akihito Kawazoe; Takuma Irie; Nozomu Fuse; Akihiro Sato; Tomonori Yano; Kohei Shitara
Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor

病例报告: MLH1启动子高甲基化的胰腺髓样癌，诱导错配修复缺陷，用免疫检查点抑制剂成功治疗

FRONTIERS IN ONCOLOGY
IF3.3
2025-03-270
OAAI
Ohtsubo, Koushiro; Sato, Shigeki; Sakaguchi, Hiroyuki; Kotani, Hiroshi; Nishiyama, Akihiro; Yamashita, Kaname; Yano, Seiji; Toshima, Fumihito; Inoue, Dai; Gabata, Toshifumi; Ikeda, Hiroko; Watanabe, Atsushi; Notohara, Kenji; Fujisawa, Takao; Nakamura, Yoshiaki; Yoshino, Takayuki; Miyake, Kunio; Miwa, Kazuhiro; Takeuchi, Shinji

研究方向

暂未获取到该数据
T
Takayuki Yoshino
H 指数:88论文数:1,566被引数:4.9万
H
Hideaki Bando
H 指数:42论文数:595被引数:7,387
H
Hiroya Taniguchi
H 指数:36论文数:433被引数:7,637
K
Kohei Shitara
H 指数:79论文数:1,129被引数:3.5万
D
Daisuke Kotani
H 指数:26论文数:365被引数:4,109
E
Eiji Oki
H 指数:70论文数:1,185被引数:1.8万
A
Akihito Kawazoe
H 指数:38论文数:380被引数:9,343
S
Saori Mishima
H 指数:19论文数:139被引数:2,172
Y
Yoshito Komatsu
H 指数:54论文数:829被引数:1.5万
S
Shinji Ohno
H 指数:62论文数:565被引数:2.3万